课题基金 / 基金详情

项目摘要

项目成果

LYNDA CHIN的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Core B will provide a constant resource of mice harboring melanomas that express BRAF*, including pairs of tumor biopsies that are sensitive or resistant to BRAFi. The integrative power of this core lies in interacting and intersecting with parallel samples from human melanomas in Core A, providing cross-species triangulation of genetic elements that confer tumor microenvironment-specific phenotypic effects. This core will provide not only a bank of Braf* mouse (iBIP and M3) melanoma tissues and derivative cell lines collected at baseline, post-treatment and upon relapse, but also capability to engineer new alleles ex vivo and perform preclinical therapeutic studies. The immunocompetent background and natural tumor microenvironment setting of IBIP melanomas bring a key feature to this TMEN center.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
SBIR PHASE I- TOPIC 410 - CANCER CLINICAL TRIALS RECRUITMENT AND RETENTION TOOLS FOR PARTICIPANT ENGAGEMENT.
  • 批准号:
    10269289
  • 项目类别:
  • 资助金额:
    $39.99万
  • 财政年份:
    2020
  • 负责人:
    LYNDA CHIN
  • 依托单位:
Role of Tumor in Therapeutic Response and Resistance
Human Specimens
Elucidating Mechanisms of Resistance using Genetically Engineered Mouse Models
  • 批准号:
    8415139
  • 项目类别:
  • 资助金额:
    $29.4万
  • 财政年份:
    2013
  • 负责人:
    LYNDA CHIN
  • 依托单位:
海外基金